Skip to main content
Log in

Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Since the clinical impact of sarcopenia on multimodal therapy for patients with esophageal cancer is not well understood, this study was conducted to determine the influence of sarcopenia on the efficacy of neoadjuvant chemoradiotherapy (NACRT) for locally advanced esophageal cancer.

Methods

The skeletal muscle index was quantified at the level of the third lumbar vertebra on computed tomography images, and sarcopenia was defined as a skeletal muscle index that was less than the average for each gender. We compared treatment outcomes in patients with cT3 and nearly T4 thoracic esophageal squamous cell carcinoma between the sarcopenia group (n = 85) and the non-sarcopenia group (n = 72).

Results

The 5-year survival rates were 33.4% in the non-sarcopenia group and 31.5% in the sarcopenia group; these differences were not significant. The prognosis of the patients with sarcopenia was worse than that of the patients without sarcopenia in the surgery-alone group, but there was no difference between patients with and without sarcopenia in the NACRT group.

Conclusions

NACRT could be a useful option for patients with locally advanced esophageal squamous cell carcinoma, even for those with sarcopenia, without increasing the incidence of morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150

    Article  PubMed  Google Scholar 

  2. Morita M, Yoshida R, Ikeda K et al (2008) Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 143:499–508

    Article  PubMed  Google Scholar 

  3. Gebski V, Burmeister B, Smithers BM et al (2007) Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 8:226–234

    Article  PubMed  CAS  Google Scholar 

  4. Fiorica F, Di Bona D, Schepis F et al (2004) Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 53:925–930

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Saeki H, Morita M, Tsuda Y et al (2013) Multimodal treatment strategy for clinical T3 thoracic esophageal cancer. Ann Surg Oncol 20:4267–4273

    Article  PubMed  Google Scholar 

  6. Avendano CE, Flume PA, Silvestri GA et al (2002) Pulmonary complications after esophagectomy. Ann Thorac Surg 73:922–926

    Article  PubMed  Google Scholar 

  7. Fink U, Stein HJ, Wilke H et al (1995) Multimodal treatment for squamous cell esophageal cancer. World J Surg 19:198–204. https://doi.org/10.1007/BF00308626

    Article  PubMed  CAS  Google Scholar 

  8. Saeki H, Masuda T, Okada S et al (2010) Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery. Surg Today 40:626–631

    Article  PubMed  Google Scholar 

  9. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127:990S–991S

    Article  PubMed  CAS  Google Scholar 

  10. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423

    Article  PubMed  PubMed Central  Google Scholar 

  11. Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140

    Article  PubMed  CAS  Google Scholar 

  12. Harimoto N, Yoshizumi T, Shimokawa M et al (2016) Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma. Hepatol Res 46:1247–1255

    Article  PubMed  Google Scholar 

  13. Go SI, Park MJ, Song HN et al (2016) Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer 24:2075–2084

    Article  PubMed  Google Scholar 

  14. Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668

    Article  PubMed  Google Scholar 

  15. van Vledder MG, Levolger S, Ayez N et al (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99:550–557

    Article  PubMed  Google Scholar 

  16. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: part I. Esophagus 6:1–25

    Article  Google Scholar 

  17. Japan Esophageal Society (2009) Japanese classification of esophageal cancer, tenth edition: parts II and III. Esophagus 6:71–94

    Article  Google Scholar 

  18. Morita M, Egashira A, Yoshida R et al (2008) Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol 43:345–351

    Article  PubMed  Google Scholar 

  19. Morita M, Nakanoko T, Fujinaka Y et al (2011) In-hospital mortality after a surgical resection for esophageal cancer: analyses of the associated factors and historical changes. Ann Surg Oncol 18:1757–1765

    Article  PubMed  Google Scholar 

  20. Yoshizumi T, Shirabe K, Nakagawara H et al (2014) Skeletal muscle area correlates with body surface area in healthy adults. Hepatol Res 44:313–318

    Article  PubMed  Google Scholar 

  21. Saeki H, Tsutsumi S, Tajiri H et al (2016) Prognostic significance of postoperative complications after curative resection for patients with esophageal squamous cell carcinoma. Ann Surg 265:527–533

    Article  Google Scholar 

  22. Safranek PM, Cubitt J, Booth MI et al (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97:1845–1853

    Article  PubMed  CAS  Google Scholar 

  23. Ida S, Watanabe M, Karashima R et al (2014) Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol 21:3675–3679

    Article  PubMed  Google Scholar 

  24. Harada K, Ida S, Baba Y et al (2016) Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma. Dis Esophagus 29:627–633

    Article  PubMed  CAS  Google Scholar 

  25. Nishigori T, Okabe H, Tanaka E et al (2016) Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer. J Surg Oncol 113:678–684

    Article  PubMed  Google Scholar 

  26. Awad S, Tan BH, Cui H et al (2012) Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31:74–77

    Article  PubMed  Google Scholar 

  27. Yip C, Goh V, Davies A et al (2014) Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 24:998–1005

    Article  PubMed  Google Scholar 

  28. Arends J, Bodoky G, Bozzetti F et al (2006) ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 25:245–259

    Article  PubMed  CAS  Google Scholar 

  29. Prado CM, Lieffers JR, McCargar LJ et al (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635

    Article  PubMed  Google Scholar 

  30. Tan BH, Brammer K, Randhawa N et al (2015) Sarcopenia is associated with toxicity in patients undergoing neo-adjuvant chemotherapy for oesophago-gastric cancer. Eur J Surg Oncol 41:333–338

    Article  PubMed  CAS  Google Scholar 

  31. Lieffers JR, Bathe OF, Fassbender K et al (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Grotenhuis BA, Shapiro J, van Adrichem S et al (2016) Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer. World J Surg 40:2698–2704. https://doi.org/10.1007/s00268-016-3603-1

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We wish to thank Akio Nagaoka for assisting with the preparation of the manuscript. This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sport, Science and Technology of Japan (16K10502).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Saeki.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saeki, H., Nakashima, Y., Kudou, K. et al. Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?. World J Surg 42, 2894–2901 (2018). https://doi.org/10.1007/s00268-018-4554-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-018-4554-5

Navigation